Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
5 results loaded, newest first. End of these results.
CEO David Ricks said the company is expanding manufacturing capacity for its new oral obesity treatment, adding that it is gaining ground among patients starting GLP-1 pills. Ricks told CNBC that Foundayo accounts for roughly one-third of new oral GLP-1 prescriptions.
Eli Lilly broke ground in Houston to expand factory capacity for Foundayo, its newly launched obesity pill, and CEO Dave Ricks said the drug has won one-third of new GLP-1 pill starts. The company is also targeting market share versus Novo Nordisk in oral obesity drugs.
LLY Ceo on Cnbc
On CNBC’s “ Mad Money Lightning Round,” Jim Cramer said Lockheed Martin Corporation (NYSE: LMT ) is “sensational” and its CEO is “fantastic.” According to recent news, the company received a major U.S. government contract modification on July 29 for PAC-3 Missile Segment Enhancement interceptors. Ameriprise Financial,
Millions of Medicare beneficiaries will gain access to obesity drugs for the first time starting Wednesday under CMS’ temporary Bridge program, a federal initiative designed to expand GLP-1 obesity drug coverage for eligible seniors at a $50 monthly copay. The program marks a major shift in Medicare coverage. While Med